Physician profile
Dennis H Kraus
NPI 1841279221
$159,313.74
in general payments reported to CMS, 2019-2025
12 companies · $132K in 2025
The $132K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $25.36 · 2021: $3,555 · 2022: $85.41 · 2023: $1,226 · 2024: $22K · 2025: $132K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $138K · Travel and Lodging: $13K · Food and Beverage: $4,684 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $137,962.30 |
| Travel and Lodging | $12,717.04 |
| Food and Beverage | $4,683.80 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $114,361.16 | 2025 | Harmonic, Dermabond |
| Medical Device Business Services, INC. | $34,865.85 | 2024-2025 | Harmonic, Dermabond |
| Intuitive Surgical, INC. | $4,828.59 | 2021-2025 | Da Vinci Surgical System |
| Ethicon INC. | $2,399.93 | 2025 | Monocryl, Vicryl, Dermabond |
| Merck Sharp & Dohme LLC | $1,362.50 | 2024 | |
| Ecs Opco 1 LLC | $680.51 | 2024-2025 | Bioflo, Cook Spectrum, Piccolo Medical |
| Astrazeneca Pharmaceuticals Lp | $299.83 | 2022-2024 | Tagrisso |
| Regeneron Healthcare Solutions, INC. | $217.63 | 2019-2020 | |
| Organogenesis INC. | $139.82 | 2025 | Puraply Wound Matrix |
| Stryker Corporation | $99.30 | 2024 | |
| Foundation Medicine, INC. | $40.50 | 2019 | |
| Kls-Martin L.P. | $18.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Kraus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.